Reitan Colleen F — SEC Form 4 filings
SEC reporting owner CIK 1740730. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-05-20 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 36 shares, $10,363 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 18 legs across 3 filings — 64,048 shares, $9,710,964 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 46,012 shares @ $27.95 ($1,285,851) in MYRIAD GENETICS INC, filed 2024-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Director | 4 | 2 legs · 36 sh · $10,363 | 17 legs · 18,036 sh · $8,425,113 | 7 |
| MYRIAD GENETICS INC (MYGN) | Director | 4 | — | 1 leg · 46,012 sh · $1,285,851 | 3 |
Form 4 filings — Reitan Colleen F
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | MYRIAD GENETICS INC (MYGN) | Grant/award (A): 59,701 @ $0 | EDGAR |
| 2026-05-22 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 671 @ $0 · Grant/award (A): 1,441 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Option exercise (M): 18,000 @ $100.65 · Sale (S): 1,645 @ $457.44 · Sale (S): 1,888 @ $458.86 · Sale (S): 1,403 @ $459.73 · Sale (S): 473 @ $460.71 · Sale (S): 2,290 @ $461.92 · +12 more | EDGAR |
| 2025-06-06 | 4 | MYRIAD GENETICS INC (MYGN) | Grant/award (A): 49,796 @ $0 | EDGAR |
| 2025-05-12 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Purchase (P): 32 @ $286 · Purchase (P): 4 @ $302.67 · Sale (S): 36 @ $232.86 · Grant/award (A): 775 @ $0 · Grant/award (A): 1,558 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | MYRIAD GENETICS INC (MYGN) | Sale (S): 46,012 @ $27.95 | EDGAR |
| 2024-06-07 | 4 | MYRIAD GENETICS INC (MYGN) | Grant/award (A): 15,695 @ $0 | EDGAR |
| 2024-05-20 | 4 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/award (A): 5,228 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1740730 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →